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Abstract
Objectives The purpose of this pictorial review is to present a
wide spectrum of prostate multiparametric MRI (mp-MRI)
pitfalls that may occur in clinical practice, with radiological
and pathological correlation.
Methods All examinations were performed according to
ESUR Guidelines protocols.
Results and Conclusion mp-MRI imaging of the prostate of-
ten leads to interpreting doubts and misdiagnosis due to the
many interpretative pitfalls that a tissue, whether healthy or
treated, may cause. These Bfalse-positive^ findings may occur
in each stage of the disease history, from the primary diagnosis
and staging, to the post-treatment stage, and whether they are
caused by the tissue itself or are iatrogenic, their recognition is
critical for proper treatment and management. Knowledge of
these known pitfalls and their interpretation in the anatomical-
radiological context can help radiologists avoid misdiagnosis
and consequently mistreatment.
Main Messages
• Some physiological changes in the peripheral and central
zone may simulate prostate cancer.
• Technical errors, such as mispositioned endorectal coils,
can affect the mp-MRI interpretation.
• Physiological changes post-treatment can simulate
recurrence
Keywords Prostate . mp-MRI . Pitfalls . ProstateMRI .
Differential diagnosis
Introduction
In the past two decades, technological innovations related to
scientific research in the diagnosis of prostate cancer (PCa)
have allowed magnetic resonance imaging (MRI) to become
the current main imaging modality for the detection, localiza-
tion, staging, grading and response assessment to therapy
[1–4]. Great interest has been shown in multiparametric
MRI (mp-MRI), which combines anatomic T2-weighted
(T2W) imaging with functional techniques. The detection of
PCa on T2W can be confounded by false-positive findings
such as prostatitis, post-biopsy haemorrhage, benign prostatic
hyperplasia, fibrosis, radiation and hormonal tissue changes
[5, 6]. In order to improve the diagnostic accuracy of PCa
imaging, functional MR imaging techniques have been ap-
plied, such as Diffusion-Weighted MR Imaging (DWI)
[7–9], proton (1H) MR Spectroscopic Imaging (MRSI)
[10–12], and Dynamic Contrast-Enhanced MR Imaging
(DCE-MRI) [13]. The combination of anatomic, biological
and metabolic information offered by multiparametric MRI
(mp-MRI) provides a promising imaging tool for improving
many aspects of PCa management. Moreover, mp-MRI has
recently also been proposed as a tool that is more useful than
other imaging procedures for the diagnosis of local recurrence
of PCa after radiation treatment or radical prostatectomy
[14–18]. In order to allow for a standardized interpretation,
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and to objectively visualize the contribution of mp-MRI to
predict the presence of significant cancer, a scoring system
similar to that employed successfully by breast radiologists
(BI-RADS) [19], has been designed for mp-MRI (PI-RADS)
[20]. In this scoring system, every imaging technique (T2W,
DW, DCE-MRI and MRSI) is scored on a five-point scale,
based on the probability that a combination of mp-MRI find-
ings on T2w, DWI and DCE findings correlates with the pres-
ence of a clinically significant cancer on each portion of the
gland, as recently illustrated on the PI-RADS v2. Because of
multiple diagnostic misunderstandings that may arise from the
individual parameters forming the study protocol, the system
of Bscore^ with PI-RADS was introduced. Each value
assigned to each sequence is weighted in relation to the se-
quence considered to be Bdominant^ for each zone of the
gland; the DWI is considered the main sequence for the pe-
ripheral zone (PZ), while the T2 is the main sequence for the
transition zone (TZ). An accurate assessment of an mp-MRI,
in addition to the PI-RADS score, requires a comprehensive
evaluation of the gland, including unavoidable knowledge of
anatomy, pathology and clinical data in order to avoid certain
diagnostic pitfalls, both false-positive and false-negative inter-
pretations, that prostate MRI can show [21]. In this paper, we
present a collection of pitfalls of interpreting prostate mp-MRI
and propose a series of solutions for difficult cases (Tables 1
and 2).
Pitfalls in Primary Diagnosis
Bilateral Basal Hypointense Zones (moustache sign)
It is very common to find at the base of the prostate gland
bilateral and usually symmetric areas (moustache-like) of ho-
mogeneous low signal intensity areas on T2-weightedmorpho-
logic images located on either side of the ejaculatory ducts.
These zones also show restricted diffusion with low ADC
values on the ADC maps, sometimes symmetric contrast en-
hancement on perfusion sequences and increased choline
peaks onMRSI [22]. All these malignant-lookingmorphologic
and functional features can erroneously lead to the diagnosis of
bilateral PCa. These symmetrical areas are due to compression
of the central zone by benign prostatic hyperplasia (BPH)
against the transition zone (Fig. 1) These typical oval-shaped
areas usually appear asymmetric between them, and when this
happens, the coronal T2-weighted sequence is the most accu-
rate to settle the differential diagnosis. Morphological aspects
of the moustache sign include symmetrical oval shape, with
sharp margins and homogeneous dark signal intensity (SI),
where foci of PCa generally have more heterogeneous appear-
ance with ill-defined margins. Sometimes a similar appearance
may be due by an ectopic stromal BPH nodule, whereas an
adenomatous BPH ectopic nodule or a cystic atrophy can be
easily recognized by the hyperintense SI. Compressed central
zone usually does not show enhancement, whereas protrusion
of BPH nodules does. The use of sagittal and/or coronal images
is crucial for this differentiation, as compression of the central
zone is never continuous to PCa arising in the PZ (Fig. 1c).
Median Posterior Hypointense Area at the Middle Third
of the Gland
T2-weighted morphologic images can show a median low
signal intensity area at the middle third of the posterior zone.
This posterior nodular-shaped area may show low ADC
values, with less or no contrast enhancement on perfusion
sequences. This aspect may be a variant of the previously
described Bmoustache sign^, in which the central zone ap-
pears compressed between the transition and peripheral zone,
taking a particular kind of shape called a reversed teardrop.
The use of the coronal plane is very important to demonstrate
the continuity and symmetry of this area with the rest of the
central portion (Figs. 2 and 3).
Transition Zone Prostate Cancer Versus BPH Foci
of Stromal Hyperplasia
Amarkedly low signal intensity focus in the transition zone on
T2-weighted imaging is usually related to a focus of stromal
hyperplasia (SH), but TZ cancers can also show a markedly
homogeneous low signal intensity (erased charcoal sign) with
ill-defined or well-defined margins and an amorphous, lentic-
ular (lens-like), round or oval shape [23] (Fig. 4). TZ cancers
occur with a relatively low frequency, accounting for approx-
imately 30 % of all PCa. They generally have a lower histo-
logical grade and remain confined to the prostate, sometimes
resulting in a large tumour volume upon detection. The detec-
tion rate of TZ cancer on the basis of T2-weighted images
alone range between 56 % and 63 % [24–26]. Recent studies
reported that quantitative ADC values derived from DWI
could improve the diagnostic accuracy in differentiating TZ
cancers (0.94–1.37×10–3 sec/mm2) from BPH nodules of SH
(1.34–1.79×10–3 sec/mm2) [23, 27–30]. The lower the ADC
values, the higher the probability of PCa. However, consider-
able overlap still exists and cannot be used in clinical practice.
SH enhances in a way that is similar to TZ cancer; for this
reason, we believe that dynamic contrast-enhanced MR imag-
ing parameters alone are not helpful for differentiating TZ
cancer from SH. Nevertheless, although quantitative perfusion
parameters alone are not effective in the differentiation of TZ
cancer from SH, combining the K trans parameter with the
ADC shows the possibility of improving this differentiation
compared to ADC mapping alone [23]. T2-weighted imaging
is actually considered the more reliable sequence in differen-
tiating SH from TZ cancers, by the identification of distinctive
SH typical features like the surrounding subtle pseudocapsule,
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heterogeneous signal intensity, round shape and well-defined
margins [16, 31, 32].
Ectopic BPH Nodule
BPH is a nodular, regional growth with a variegated gross
appearance resulting from the inhomogeneous and irregular
mixture of glandular and stromal tissue. Although BPH nod-
ules are mostly located centrally in the enlarged TZ, they
sometimes may arise in the PZ of the prostate. A focal
peripheral nodule of remarkably low, intermediate or some-
times high signal intensity on T2-weighted images charac-
terized by sharply-defined margins, round or oval shape and
surrounded by a subtle pseudocapsule should not be
mistaken for a peripheral PCa. T2-weighted morphologic
images can sometimes show a median low signal intensity
area at the middle third of the posterior zone, continuous to
the posterior portion of an adenoma. This posterior bulging
portion of BPH can show a nodular shape, low ADC values,
and an enhancement similar to the central portions of the
adenoma. The use of sagittal and/or coronal planes is very
important to demonstrate the continuity with the adenoma.
Ectopic BPH nodules enhance in a way that is similar to
PCa; for this reason, DCE-MRI is not helpful for
distinguishing between ectopic BPH nodules and peripheral
foci of PCa. Quantitative ADC values could improve the
diagnostic accuracy in discerning peripheral PCa from ec-
topic BPH nodule: the higher the ADC values, the higher
the likelihood of ectopic BPH nodule (Figs. 5 and 6) Ectopic
BPH nodules sometimes contain tiny bright spots corre-
sponding to dilated acini, and this is a characteristic that
can be used to distinguish them from PZ PCa.
Granulomatous Prostatitis after Intravesical Instillation
of BCG
The granulomatous reaction that occurs in prostate tissue fol-
lowing the topical instillations of BCG after resection of blad-
der cancer can present MRI features very similar to those
found in prostate cancer [33]. Granulomatous prostatitis, in
the most common pattern, presents in T2-weighted images
as an area of low SI, with ill-defined margins and variable
shape, from nodular to band-like. ADC maps in the area of
granulomatous prostatitis may present restriction of diffusion
with even very low ADC values, due to the high cellular
density. DCE-MRI presents with moderate enhancement, not
intense, as it generally occurs in prostate cancers (Fig. 7).
Table 1 Pitfalls classification
based on categories before
treatment
Category Pitfall
1. Pitfalls in primary diagnosis 1. Bilateral basal hypointense zones (moustache sign)
2. Median posterior hypointense area at the middle third of the gland
3. Transition zone prostate cancer versus BPH foci of stromal hyperplasia
4. Ectopic BPH nodule
5. Granulomatous prostatitis after intravesical instillation of BCG
6. Hypertrophic anterior fibromuscular stroma
7. Periprostatic venous plexus and neurovascular bundle
2. Pitfall in the staging 1. T3 versus T2 (overlapping with pitfalls in primary diagnosis:
granulomatous prostatitis, periprostatic venous plexus and
neurovascular bundle)
5. Bone findings
6. Controversial on lymph nodes
3. Artifacts/iatrogenic changes 1. Mispositioned endorectal coil
2. Post-biopsy changes
3. Lymphoceles
Table 2 Pitfalls classification based on categories after treatment
Category Pitfall
4. Pitfalls after surgical
treatment
1. Residual glandular tissue
2. Fibrosis
3. Retained seminal vesicles
4. Sealed off veins
5. Prominent periprostatic venous plexus
6. Residual verumontanum
5. Pitfalls after radiation/
hormone deprivation
therapy and after
focal therapies
1. RT-induced capsular irregularity may
hinder evaluation of extracapsular
extension
2. Focal regions of T2-hypointensity may
represent treated tumour and not local
recurrence
3. Focal therapies-induced enhancing of
reactive prostate tissue may hamper the
assessment of persistent/residual disease
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Hypertrophic Anterior Fibromuscular Stroma
Anterior fibromuscular stroma (AFMS), according to the
McNeal zonal anatomy distinction, is the most anterior
portion of the gland, situated between the two lobes that
constitute the transition zone (TZ), which often appears to
be flattened by them. That zone is basically formed by
muscle cells intermingled with dense connective tissue,
Fig. 1 A 74-year-old man with PCa at the apex and bilateral basal
hypointense nodular zones (moustache sign) (white arrows). a Axial
T2-weighted fast spin-echo image (4564/110). b axial T2-weighted fat
saturated fast spin-echo image (4941/116) and c coronal T2-weighted fast
spin-echo image (5059/120) showing symmetric, bilateral, well-defined
homogeneous hypointense zones at the base of the prostate gland. dAxial
perfusion gradient-echo T1-weighted, e gradient-echo T1-weighted
subtracted image and f colour DCE (dynamic contrast enhance) MR
map displaying mild enhancement of the hypointense zones. g Axial
DWI image with b value = 1000, h 3000 mm2/sec, and i ADC map
showing restricted diffusion phenomena of water molecules in the
hypointense basal sites detected on T2-weighted images. According to
the PIRADSv2 scoring system, the score for T2, DCE and DWI is,
respectively: 3, + and 4; the overall score is 4, which means highly
clinically significant cancer is likely to be present. i Photomicrograph
from a prostatectomy specimen shows the compression exerted by BPH
on the central zone, bilaterally (black arrows)
Fig. 2 a Axial T2-weighted fast spin-echo image (5525/110) and b axial
T2-weighted fat saturated fast spin-echo image (4941/116) showing a
hypointense zone at the mid-peripheral gland in the median posterior
location. c Axial perfusion, gradient-echo T1-weighted, d gradient-echo
T1-weighted subtracted image and e colour DCE MR map displaying
mild enhancement of the hypointense zone. f Axial DWI image with b
value = 1000 and g 3000 mm2/sec and h ADC map showing restricted
diffusion phenomena of water molecules in the hypointense focus
detected on T2-weighted images (white arrows). According to the
PIRADSv2 scoring system, the score for T2, DCE and DWI is,
respectively: 3, + and 4; the overall score is 4, which means highly
clinically significant cancer is likely to be present. i Photomicrograph
shows the area in the posterior middle third of the gland (black arrows)
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without the presence of glandular tissue. Because of its histo-
logical constitution on T2-weighted images, it appears homo-
geneously hypointense, with a signal intensity similar to that
of PCa. It is possible to find in some cases, especially in the
presence of a modestly sized adenoma, a sometimes
asymmetrical hypertrophy of the AFMS, which can mimic
the presence of a PCa. In this case, DWI and DCE-MRI be-
come essential to distinguish a zone of hypertrophic AFMS,
because such a zone does not show restriction on DWI or
enhancement on DCE-MRI [34] (Fig. 8).
Fig. 3 Median posterior hypointense area at the middle third of the gland
with no ERC. a Axial T2-weighted fast spin-echo image and b axial Fat
Saturated T2-weighted showing an ill-defined hypointensemedian area at
the middle third of the gland. c ADC map showing mild restriction of
water molecules diffusivity in the hypointense focus detected on T2-
weighted images. d Axial perfusion gradient-echo T1-weighted, and e
colour DCE MR map showing mild enhancement of the hypointense
zone
Fig. 4 a Axial T2-weighted fast spin-echo image (5525/110). b Axial
DWI image with b value = 1000. c ADC map showing mild restricted
diffusion phenomena of water molecules in the hypointense focus
detected on T2-weighted images (white arrows).d gradient-echo T1-
weighted subtracted image and e colour DCE MR map displaying mild
enhancement of the stromal nodule. According to the PIRADSv2 scoring
system, the score for T2, DCE and DWI is, respectively: 2, − and 3; the
overall score is 3, which means the presence of clinically significant
cancer is equivocal. f Photomicrograph (50×) showing the BPH stromal
nodule
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Periprostatic Venous Plexus and Neurovascular Bundle
The proximity of both the periprostatic venous plexus and
neurovascular bundle (NVB) to the peripheral zone may cre-
ate a clinical challenge in assessing for focal peripheral zone
lesions. The periprostatic venous plexus or NVB will have a
discrete rounded appearance when viewed en face on axial
slices. In addition, these structures exhibit decreased T2 signal
intensity and a signal void on the ADC map, and could be
erroneously considered suspicious for a lesion within the pe-
ripheral zone. Nevertheless, the periprostatic venous plexus or
NVB may be correctly identified given the typical location
coursing along the lateral margin of the peripheral zone and
rounded contour if viewed en face on an individual axial slice,
Fig. 5 Ectopic stromal BPH nodule in the right peripheral zone (white
arrows). a Axial T2-weighted fast spin-echo image (5045/110), b axial
T2-weighted fat saturated fast spin-echo image (45461/116) and c coronal
T2-weighted fast spin-echo image (5565/120) showing a round sharply
defined nodule of low signal intensity surrounded by a pseudocapsule in
the peripheral zone of the prostate at the right peri-apical location. dAxial
DWI image with b value = 1000 mm2/sec and e = 3000 mm2/sec, and f
ADC map showing remarkable diffusion restricted phenomena. g Axial
perfusion gradient-echo T1-weighted and h gradient-echo T1-weighted
subtracted image showing avid enhancement of the nodule. According to
the PIRADSv2 scoring system, the score for T2, DCE and DWI is,
respectively: 4, + and 3; the overall score is 3, which means the
presence of clinically significant cancer is equivocal. i Pathologic
correlation after prostatectomy yielded BPH (black arrows)
Fig. 6 Ectopic nodule in the right
peripheral zone with no ERC. a
Axial T2-weighted fast spin-echo
image showing an hypointense
well circumscribed nodule in
right peripheral zone with an
evident peripheral capsule. b
ADCmap and c axial DWI image
with b value = 3000 mm2/sec,
showing no significant restriction
of water diffusivity. d Axial
perfusion gradient-echo T1-
weighted image shows marked
and early enhancement
simultaneous to other nodule
constituents of the adenoma
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combined with the tubular morphology when tracked across
consecutive slices and potential visualization of a similar-
appearing structure on the contralateral side. Generally, the
T2-weighted images, given their higher in-plane spatial reso-
lution, are helpful to show that a potential lesion identified on
DWI or DCE-MRI represents the normal periprostatic venous
plexus or NVB. In addition, the expected delayed venous
enhancement of the periprostatic venous plexus (and possibly
of the NVB, given its intimate association with small venous
structures) may be more readily apparent on inspection of the
pre-processed dynamic contrast-enhanced images than on the
post-processed parametric perfusion maps, given the greater
anatomic clarity of the raw contrast-enhanced images [21]
(Fig. 9).
Pitfalls in the Staging
Local Staging
At the apex: Pseudo T3a stage is caused by an anatomical
variation of the shape of the apex, when PZ prostatic tissue
is present along the posterior aspect of the distal urethra.When
involved by tumour, it can simulate subapical T3 disease.
At the base: bulging BPH nodules along the root of seminal
vesicles simulates T3b stage.
Any location: granulomatous prostatitis commonly infil-
trates the periprostatic fat and simulates T3a disease.
At the postero-lateral portion of the gland: periprostatic
venous plexus and neurovascular bundle.
Fig. 7 a Coronal T2-weighted fast spin-echo image (5525/110) and b
Axial T2-weighted fast spin-echo image (5525/110) showing diffuse
peripheral hypointensity in a patient who underwent intravesical
instillation of BCG (white arrows). c ADC map showing high restricted
diffusion phenomena of water molecules in the hypointense posterior area
detected on T2-weighted images. d Axial DWI image with b value =
1000 and e gradient-echo T1-weighted subtracted image show slight
enhancement of the area. f Histological picture shows diffuse
granulomatous inflammation with multinucleated giant cells adjacent to
a prostatic gland, (100×, H&E) (black arrow)
Fig. 8 Hypertrophic anterior fibromuscular stroma (white arrows). a
Axial T2-weighted fast spin-echo image (5045/110), b coronal T2-
weighted fast spin-echo image (5565/120) showing hypertrophic area
of low signal intensity between the small transition zone lobes. c Axial
DWI image with b value = 1000 mm2/sec and d ADC map showing no
diffusion restricted phenomena. e Axial perfusion gradient-echo T1-
weighted subtracted image showing late mild enhancement of the zone.
According to the PIRADSv2 scoring system the score for T2, DCE and
DWI is, respectively: 4/5, − and 2; the overall score is 4 (based on
dominant sequence), which means the presence of clinically significant
cancer is likely to be present
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The pitfalls mentioned above are representative of T3 vs.
T2, and overlap with pitfalls in primary diagnosis.
Benign Bone Findings Mimicking Prostate Cancer
Metastases
Focal enhancing zones in the pelvic bone structures detected
on contrast-enhanced T1-weighted images are usually suspi-
cious for prostate cancer metastases (Fig. 10). A careful anal-
ysis of morphology of such findings on T2-weighted images
and of behaviour in diffusion images is mandatory to exclude
malignancy. For example, these focal enhancing zones may
represent hyperplastic islands of bone-marrow (which appear
as an isointense or slight hypointense well or ill-defined area
on T2-weighted images) (Fig. 11), or benign bone tumours
like enchondroma (which appears as a lobulated lesion with
polycyclic margins, internal septations, high signal intensity
on T2-weighted images with small foci of low signal intensity
due to calcified chondroid matrix (Fig. 12).
Controversial on Lymph Nodes
Another role of MRI in the evaluation of patients with PCa is
the detection of pathologically involved pelvic lymph nodes.
According to standard criteria on conventional MRI, lymph
nodes are classified as malignant if the short-axis diameter is
elongated and exceeds 10 mm, or is rounded and exceeds
8 mm. Unfortunately, it could happen that these kind of lymph
nodes are disease free, or that lymph nodes less than 10 mm
considered as non metastatic are pathologically involved at
histology [35]. The use of lymphotropic, superparamagnetic
iron oxide nanoparticle contrast agents can improve the Sensi-
tivity (Se) and Specificity (Spe) of MRI in the detection of
lymph nodemetastases. These nanoparticles have a monocrys-
talline, inverse spinel, superparamagnetic iron oxide core, con-
tain a dense packing of dextrans to prolong their time in circu-
lation, and are avidly internalized by macrophages within
lymph nodes and result in changes in the magnetic properties
detectable by MRI [36] After injection of nanoparticles, nodes
could be consideredmalignant when one of the following three
criteria is present: a decrease in signal intensity (SI) of less than
30 % on T2Wor gradient-echo sequences; a heterogeneous SI
(giving the entire node a mottled appearance), discrete focal
defects (isolated islands of high SI), or both; a central area of
hyperintensity (excluding a fatty hilum), but a peripheral de-
crease in SI. In a study of 80 patients with T1-3 PCa who
subsequently underwent surgical lymph node resection or
targeted lymph node biopsy for a total of 334 lymph nodes
evaluated with direct MRI-histological correlations, conven-
tional MRI detected pathologically involved nodes with a Se
of 35.4 % and Spe of 90.4 %, compared with 90.5 % Se and
97.8 % Se for MRI with nanoparticle contrast agents [36].
Pitfalls after Treatment
Radical prostatectomy has been performed for more than a
century [37], and remains the most common treatment choice
Fig. 9 Prominent peri-prostatic bundle with no ERC. a Axial T2-
weighted fast spin-echo image showing an ill-defined hypointense area
in posterior left peripheral zone, suspected for cancer. bAxial DWI image
with b value = 3000mm2/sec, and cADCmap image showing no areas of
significant restriction of water diffusivity. dAxial perfusion gradient-echo
T1-weighted image, and e colour DCE MR map showing no enhancing
areas in left peripheral zone with and enhancing neuro-vascular bundles
adherent to the glandular profile. According to he PIRADSv2 scoring
system, the score for T2, DCE and DWI is, respectively: 2, + and 4; the
overall score is 4 (based on dominant sequence), which means that the
presence of clinically significant cancer is equivocal
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in patients with organ-confined prostate cancer [38]. It in-
volves the removal of the entire prostate, the seminal vesicles,
and the ampullary portions of the vasa deferentia, with the
formation of a vesicourethral anastomosis. Whenever possi-
ble, the surgical procedure is tailored to preserve the
neurovascular bundles responsible for erectile function as well
as the external sphincter responsible for urinary continence.
The likelihood of simultaneous achievement of all three de-
sired outcomes (cancer-free status, continence, and potency,
sometimes called the Btrifecta^) after radical prostatectomy
has been reported to be 60 %–91 % after 18–24 months
[39–41].
Fig. 10 a Axial post-contrast T1-weighted fat saturated 3D FLASH
(VIBE) axial image showing a small enhancing area in the right
ischiopubic ramus. b Axial T2-weighted fast spin-echo (6330/115) and
d coronal T2-weighted (5230/114) images display a small round
hypointense area, which appears slightly hyperintense (white arrows)
on c axial T2-weighted fat saturated image (8450/115). e Bone scan
showing uptake of radiotracer in the right ischiopubic ramus. All these
findings are consistent with bone metastasis. In addition, the reference
standard was the drop of PSA value after hormonotherapy (from 18 ng/
mL to 4.5 ng/mL)
Fig. 11 a Post-contrast T1-weighted fat saturated 3D FLASH (VIBE)
axial image and b coronal T1-VIBE reconstructed image showing a small
enhancing focus in the left iliac bone. cNo bone alterations detected in the
corresponding site on coronal T2-weighted fast spin-echo image
(7940/112) (white arrows). d No areas with uptake of radiotracer are
displayed at bone scan. These findings exclude the hypothesis of bone
metastasis
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Residual Glandular Tissue, Fibrosis and Granulation
Tissue
The presence of soft tissue in the prostatectomy bed that is
isointense to muscle on T1-weighted images and slightly hy-
perintense to muscle on T2-weighted images should be con-
sidered as strongly suggestive of local recurrence. The most
common site of postoperative local recurrence is the
vesicourethral anastomosis [42]. Other common sites of local
recurrence are retrovesical (between urinary bladder and rec-
tum), within retained seminal vesicles, or at the anterior or
lateral surgical margins of the prostatectomy bed (e.g., abut-
ting the levator ani muscles) [43]. In most cases, local recur-
rence can be readily distinguished from normal postoperative
fibrosis, which is of low signal intensity compared with mus-
cles on images obtained with all sequences (Fig. 13). Howev-
er, if the MRI was performed shortly after surgery, there is a
possibility of finding the granulation tissue within the surgical
site, particularly in the perianastomotic region where it can
mimic the appearance of tumour recurrence [43]. In these
circumstances, both T2-weighted and contrast-enhanced MR
imaging have a limited role. Recurrent tumour tends to be
slightly hyperintense on T2-weighted sequences and avidly
enhances in the arterial phase with wash-out during the venous
phase, while post-operative granulation-tissue may present the
same features found on T2 and DCE [14–16]. Sometimes it is
very difficult to distinguish between a local recurrence nodule
and residual glandular healthy tissue, because both appear
slightly hyperintense compared to muscles on T2-weighted
images and may be hypervascular on perfusion images. In
these cases, the differential diagnosis may be achieved by
means of MRSI and DWI (Fig. 14). The ratio of choline
(Cho) plus creatine (Cr) to citrate (Ci) in the voxels of interest
may help in disclosing the most likely origin of the tissue in
the post-prostatectomy bed. Fibrotic/scar tissue is likely when
Cho+Cr/Ci<0.2; residual healthy prostatic gland tissue when
Cho+Cr/Ci>0.2 and<0.5; probably recurrent prostate cancer
tissue when Cho+Cr/Ci>0.5 and<1; and definitively recur-
rent prostate cancer tissue when Cho+Cr/Ci>1 [43]. The
ADC values are a very useful tool to distinguish between
loco-regional relapse and residual glandular tissue, and also
to express a likelihood of the aggressiveness of the local re-
currence. In a recent study, Panebianco et al. found that the
mean and standard deviation of ADC values were 0.5±
0.23 mm2/s for high-grade recurrence, 0.8±0.09 mm2/s for
intermediate-grade recurrence, 1.1±1.17 mm2/s for low-
grade relapse and higher than 1.3 mm2/s (mean ADC values
1.4; range 1.3–1.7) for residual glandular healthy tissue [17].
Retained Seminal Vesicles
Retained seminal vesicles are observed in approximately 20%
of patients after prostatectomy [44]. On computed tomogra-
phy (CT), retained seminal vesicles may be confused with
soft-tissue recurrence; however, the vesicles are usually easily
recognizable on MR images, as they tend to maintain their
normal convoluted tubular appearance and high intraluminal
signal intensity on T2-weighted images [45]. Alternatively,
low signal intensity, relative to that of muscle, on both T1
and T2-weighted images, presumably as a result of fibrosis,
may be seen in seminal vesicle remnants [44] (Fig. 15). Care-
ful analysis of DCE and DWI images is required to exclude
local recurrence at the site previously occupied by the seminal
vesicles, because it shows no marked enhancement and no
restricted diffusion of water molecules (Fig. 16).
Sealed Off Veins
Sometimes, a prominent sealed off venous plexus in the
post-prostatectomy fossa adjacent to the vesico-urethral
anastomosis appears as a small lobulated tissue mass with
high signal intensity on T2-fat saturated images; this tissue
does not show enhancement after intravenous injection of
contrast media and diffusion restriction of water molecules
at DWI (Fig. 17).
Prominent Periprostatic Venous Plexus
Up to now, DCE-MRI was assumed to be the most reliable
MRI for detecting local prostate cancer recurrence in patients
with biochemical progression after radical prostatectomy. In
one study, sensitivity and specificity increased respectively
Fig. 12 a Axial post-contrast T1-weighted fat saturated 3D FLASH
(VIBE) axial image showing a round, well-defined hypervascular lesion
in the right femoral head (white arrows). b Axial T2-weighted fast spin-
echo (6200/112), c coronal T2-weighted (4110/112) and d axial T2-
weighted, fat saturated spin-echo (8300/112) images display a round,
lobulated, markedly hyperintense lesion surrounded by a sclerotic rim.
These findings are consistent with enchondroma
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from 61.4 % and 82.1 % (when using unenhanced MR imag-
ing) to 84.1 % and 89.3 % (when using Bstatic^ MR imaging
sequences acquired 20, 60, and 120 seconds after administra-
tion of intravenous contrast material) [42]. Sciarra et al. [46]
Fig. 14 MR images of a 69-year-old man with prostate-specific antigen
progression (PSA serum level 1.06 ng/mL) after radical retropubic
prostatectomy, with suspected local recurrence. a Axial T2-weighted
fast spin-echo (5525/109) and b axial T2-weighted fat saturated fast
spin-echo image (5981/116) show a solid tissue on posterior
perianastomotic location in front of the rectal wall at about 33 mm from
the ureteral meatus which is hyperintense compared to pelvic muscles
(white arrows). c Axial gradient-echo T1-weighted, d gradient-echo T1-
weighted subtracted image and e DCE MR colour map showing a
positive contrast enhancement of the abnormal tissue. f Diffusion
weighted images with a b value of 1.000,g 3.000 s/mm2 and h ADC
map show no diffusion restricted phenomena, consistent with residual
glandular tissue
Fig. 13 MR images of a 64-year-old man with prostate-specific antigen
progression (PSA serum level 0.75 ng/mL) after radical retropubic
prostatectomy, with suspected local recurrence. a Axial T2-weighted
fast spin-echo (6200/112), b axial T2-weighted fat saturated fast spin-
echo (8300/112) and c sagittal T2-weighted fast spin-echo (4640/112)
show a solid tissue on posterior perianastomotic location in front of the
rectal wall at about 40 mm from the ureteral meatus, which is slightly
hyperintense compared to pelvic muscles (white arrows). d Axial
Gradient-echo T1-weighted image and e Gradient-echo T1-weighted
subtracted image showing a remarkable enhancement of the
pathological tissue f Axial ADC map reconstructed from images
obtained at b values of 0, 500 and 1000 s/mm show a dark area
corresponding to the abnormal hyperintense tissue seen on T2-weighted
images (black arrow). All these findings are consistent with local
recurrence
Insights Imaging (2015) 6:611–630 621
reported areas under the receiver operating characteristic
(ROC) curves of 0.94, 0.93, and 0.96 for MR spectroscopic
imaging, dynamic contrast-enhanced MR imaging, and the
combination of both, respectively, in 50 patients at high risk
of local recurrence after radical prostatectomy. Panebianco
et al. reported that the accuracy of DWI (in particular, using b
value = 3000 s/mm2) is slightly lower than DCE (92 % versus
93 %) in depicting loco-regional relapse because DWI images
are more affected by intrinsic distortion artefacts and back-
ground noise than DCE images, although there are some cases
in which DCE is doubtful and DWI is of primary importance
for local recurrence depiction [17] (Figs. 18 and 19).
Verumontanum
The seminal colliculus or verumontanum of the prostatic ure-
thra is a landmark near the entrance of the seminal vesicles.
This microscopic recess sometimes remains in place after rad-
ical prostatectomy [47], and, when hypertrophic and inflamed,
it may mimic a local recurrence [48], showing a slightly hy-
perintense signal intensity compared to pelvic muscles on T2-
weighted images and enhancement on T1-weighted perfusion
images. DWI is very useful in such a finding, because the
remaining verumontaum does not show restriction diffusion
phenomena (Fig. 20).
Pitfalls after Radiation/Hormone Deprivation Therapy
The first important aspect to consider when evaluating possi-
ble recurrence after Radiation Therapy (RT) is that recurrence
tends to occur at the site of the primary (pre-RT) tumour [49,
50]. The relative signal intensity difference between the treat-
ed gland and a cancerous lesion is typically less than in the
Fig. 15 MR images of a 64-year-old man with prostate-specific antigen
progression (PSA serum level 0.9 ng/mL) after radical retropubic
prostatectomy, with suspected local recurrence. a Axial T2-weighted
fast spin-echo image shows, on the zone of right seminal vesicle, a
nodular tissue (white arrows) with signal intensity similar to that of
muscle. b Axial gradient-echo T1-weighted subtracted image shows no
signs of enhancement on the same location as the solid nodular tissue seen
on trasverse T2-weighted images. c Diffusion weighted images with a b
value of 1.000 and d 3.000 s/mm2 and e ADC map show no diffusion
restricted phenomena on corresponding site. These findings are consistent
with seminal vesicle remnants with fibrotic evolution
Fig. 16 MR images of a 63-year-old man with prostate-specific antigen
progression (PSA serum level 1.9 ng/mL) after radical retropubic
prostatectomy. a Axial T2-weighted fast spin-echo (6006/109) and b
axial T2-weighted fat saturated fast spin-echo image showing residual
glandular tissue. c Axial T2-weighted fast spin echo (6006/109) and d
sagittal T2-weighted fast spin echo (5059/120) showing retained seminal
vesicles, which appear as high signal intensity tubular structures (white
arrows)
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untreated gland, however, often making the lesions less con-
spicuous [18].
A focal low signal intensity area in the peripheral zone on
T2-weighted images may represent a treated tumour and not
necessarily cancer recurrence, and recurrent tumours may not
be apparent on T2WI [18]. In these situations, there may be a
role for multiparametric assessment with MRSI, DW-MR
imaging and DCE-MR imaging. In a study to evaluate pros-
tate cancer recurrence after radiation therapy, spectroscopy
was more sensitive than conventional MR imaging and digital
rectal examination (77% versus 68% and 16%, respectively),
though it was also much less specific (78 % versus 90 % for
both MR imaging and digital rectal examination) [51], prob-
ably as a result of metabolic alterations in benign tissue after
Fig. 17 MR images of a 61-year-old man with prostate-specific antigen
progression (PSA serum level 0.62 ng/mL) after radical retropubic
prostatectomy, with suspected local recurrence. a Axial T2-weighted
fast spin-echo (5170/112), b axial T2-weighted fat saturated fast spin-
echo (6920/112) and c sagittal T2-weighted fast spin-echo (4730/114)
image showing a hyperintense lobulated tissue on anterior
perianastomotic location posterior to the pubic symphysis d Axial
perfusion Gradient-echo T1-weighted subtracted image showing no
signs of enhancement of the suspicious pathological tissue. e Diffusion-
weighted images with a b value of 1.000, f 3.000 s/mm2 and g ADC map
show no diffusion restricted phenomena. The hyperintese lobulated tissue
detected in T2-weighted images represents a prominent sealed off venous
plexus (white arrows)
Fig. 18 a Axial T2-weighted fast spin-echo (6330/115) and b axial T2-
weighted fat saturated fast spin-echo image (8450/115) show, on the zone
previously occupied by the right seminal vesicle, a slightly hyperintense
lobulated tissue. c Gradient-echo T1-weighted subtracted image shows a
well-defined area of marked enhancement (arrows) on the same location
as the lobulated tissue seen on T2-weighted images. dDiffusion weighted
image with a b value of 1.000 and e 3.000 s/mm2 and f the ADC map
show no restricted diffusion signs. These findings are consistent with
prominent periprostatic venous plexus (white arrows)
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RT. Dynamic contrast-enhanced MR imaging has also been
reported to improve the detection of recurrence after RT by
showing early arterial enhancement of tumour nodules and
early washout [52] (Fig. 21). In addition, Kim et al. [53]
Fig. 19 MR images of a 68-year-old man with prostate-specific antigen
progression (PSA serum level 0.67 ng/mL) after radical retropubic
prostatectomy, with suspected local recurrence. a Axial T2-weighted
fast spin-echo (6567/111) and b axial T2-weighted fast spin-echo fat
saturated (7216/118) show on the zone previously occupied by the
proximal portion of right seminal vesicle, a hyperintense nodular tissue
(arrow). c Gradient-echo T1-weighted subtracted image and d colour
DCE map shows a well-defined area of marked enhancement (arrow)
on the same location as the solid nodular tissue seen on T2-weighted
images. e Diffusion weighted images with a b value of 3.000 s/mm2
and f ADC map show a focal area of restricted diffusion (arrow)
corresponding to the solid nodular tissue detected on T2-weighted
images and the enhancing zone seen on dynamic contrast-enhancing
images. These findings are consistent with local recurrence (white
arrows)
Fig. 20 Hypertrophic verumontanum of a 66-year-old man with
prostate-specific antigen progression (PSA serum level 0.75 ng/mL)
after radical retropubic prostatectomy. a Axial T2-weighted fast spin-
echo (6330/115), b axial T2-weighted fat saturated fast spin-echo image
(8450/115) and c sagittal T2-weighted fast spin-echo (5000/114) show a
small tissue at the bladder neck location, which is slightly hyperintense
compared to pelvic muscles (arrow). dAxial Gradient-echo T1-weighted
subtracted image showing no signs of enhancement of the suspicious
pathological tissue detected on T2-weighted images. e Axial ADC map
reconstructed from images obtained at b values of 0, 500 and 1000 s/mm2
show a bright area corresponding to the abnormal hyperintense tissue
seen on T2-weighted images, which is a finding suggestive for the
absence of restricted diffusion phenomena. f Photomicrograph from
biopsy specimen showing verumontanum
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reported that the area under the curve for predicting recurrence
after RT improved from 0.61 with T2-weighted imaging to
0.88 when DW MR imaging was added to T2-weighted im-
aging (p<0.01). In a preliminary report on the use of mp-MRI
imaging in patients suspected of having recurrence after RT,
Akin et al. [54] recently reported that the area under the curve
for two readers increased from 0.64 and 0.53 when using T2-
weighted imaging alone to 0.95 and 0.86 when using the
combination of T2-weighted, DW, and dynamic contrast-
enhanced MR imaging. Radiation treatment may also induce
irregularities of capsular profile that may hinder the evaluation
of extracapsular extension of recurrence [18]. As regards
MRSI used as a tool for monitoring response to therapy, it is
very important to know that a temporary peak of choline may
occur in the first 3 months after radiation therapy or hormone
deprivation therapy, because in the early post-treatment peri-
od, Ci concentration decreases faster than Cho and Creatine,
and the ratio Cho+Cr/Ci increases>1.5, mimicking a residual
or recurrent disease [55]. Therefore, MRSI should be per-
formed at least 3 months after radiation therapy or hormone
deprivation therapy in order to avoid this kind of pitfall.
Pitfalls after Focal Therapies
Currently, focal therapies, such as cryotherapy, high-
intensity focused ultrasound and photodynamic therapy,
are becoming a reliable and recognized form of treatment
for prostate cancer as an alternative to surgery or to radi-
ation treatment [56]. Focal treatments may be used to treat
the entire prostate or to target specific prostate regions,
and can be delivered by using a transrectal or transperineal
approach and with US or MR guidance. Depending on the
extent of the treatment, loss of zonal differentiation, thick-
ening of the prostatic capsule, and periprostatic fibrosis
and scarring may be present. In general, enhancing soft-
tissue lesions after focal treatments should be considered
suggestive of recurrence. Nevertheless, it may be difficult
to differentiate viable tumour from reactive enhancing
prostate tissue, particularly at the margins of the treated
area (Figs. 22 and 23).
After cryotherapy, heterogeneous enhancement intermixed
with areas of necrosis and thickening of the prostatic capsule,
urethra and rectal wall are seen on T1-weighed (T1w) images
[57].
After HIFU, ablation-induced changes in the region of the
lesions appear on contrast-enhanced T1w images as non-
enhancing hypointense regions with 3–8 mm thick peripheral
rims of enhancement that resolve within 3–5 months showed
that at 6 months, the prostate is of predominantly low signal
intensity on T2w images and that there is a median volume
reduction of 61 % [58]. They also concluded that the volume
of enhancing prostate tissue on the initial image after treat-
ment correlated well with serum PSA level nadir (Spearman’s
r=0.90, P<0.001) and with volume at 6 months (Pearson’s r=
0.80, P=0.001). After photodynamic therapy, MRI may be
used to assess the extent and distribution of the expected ne-
crosis in the target region. In one study [59], most patients
showed marked irregularity at the treatment boundary, that
was best appreciated on T1w images after i.v. administration
of contrast material, with areas of enhancement (viable tissue)
Fig. 21 Post-RT treatment. a Axial T2-weighted fast spin-echo image
showing an area of intermediate signal intensity in the peripheral posterior
left portion of the gland after 3 months post-RT treatment suspected for
recurrence. b Axial perfusion gradient-echo T1-weighted image shows
mild enhancement in the suspected area. c ADC map and d axial DWI
image with b value 1000 mm2/sec showing no areas of suspected
restriction of water diffusivity. e colour DCE MR map showing marked
enhancement in posterior left peripheral zone, corresponding to post-RT
outcomes
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interposed between non-enhancing low-signal-intensity re-
gions (necrosis) [18].
Enhancing soft tissue lesions after focal treatments should
be considered suggestive of residual/recurrence, just as they
are after other forms of treatment. It is important to be aware
that a recurrent lesion may present in conjunction with normal
post-treatment appearances. Furthermore, the characteristics
typically associated with recurrence on T2w images may not
represent recurrence in some cases. In some cases of recur-
rence, these features simply fail to appear [57]. Some authors
suggest that MRSI is superior to MRI for the differentiation of
cancer voxels from necrosis voxels [60], but at present, MRSI
is not widely used to aid clinical decision making, and is
therefore insufficient to give a conclusive statement. After
HIFU, the detection of recurrent or residual disease could be
hindered by diffuse or multifocal areas of low signal intensity
on T2w MRI [61]. A short time to peak enhancement, early
washout, and other pharmacokinetic parameters seen onDCE-
MRI in patients with untreated prostate cancer can also be
present in cases of recurrence after HIFU [60]. A study
showed that for prediction of local tumour progression of
prostate cancer after high intensity focused ultrasound, dy-
namic contrast-enhanced MR imaging was more sensitive
but less specific than the combination of T2-weighted and
Fig. 23 Post-MRgFUS
treatment. a Pre-treatment axial
T2-weighted fast spin-echo image
and b post-contrast subtracted
image showing a focal lesion on
the postero-lateral aspect of the
left third mid-gland with
enhancement consistent with
prostate cancer. c Post-treatment
axial T1-weighted post-contrast
subtracted image showing
ablation of the area. d ADC map
6 months after MRgFUS
treatment showing a focal zone of
restricted diffusion suspected for
local recurrence. e Post-contrast
subtracted image showing no
focus of contast enhancement.
These findings are consistent with
post-MrgFUS treatment fibrotic
tissue
Fig. 22 Post-HIFU treatment. a
Axial T2-weighted fast spin-echo
image showing an area of
intermediate signal intensity in
the anterior left portion of the
gland after 3 months post-HIFU
treatment, suspected for
recurrence. b Axial perfusion
gradient-echo T1-weighted image
shows no significant
enhancement in the suspected
area. c Axial DWI image with b
value 1000 mm2/sec, showing a
higher hyperintense area in the
anterior left portion of the
prostate, d ADC map image
showing no areas of significant
restriction of water diffusivity,
corresponding with post-HIFU
treatment outcomes
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DW MR imaging [62]. Despite the sensitivity of dynamic
contrast-enhanced imaging for the detection of progressive
tumours after ablative therapy, areas of residual benign pros-
tatic hypertrophy may show hypervascularity, thereby yield-
ing false-positive findings and limiting the specificity of dy-
namic contrast-enhanced imaging [63]. Diffusion-weighted
imaging, on the other hand, may provide greater specificity,
albeit lower sensitivity for detection of viable tumours after
ablative therapy [64]. Therefore, suspicious lesions should
always be confirmed by (targeted) biopsy.
Artefacts and Iatrogenic Changes
Mispositioned Endorectal Coil
At a standard clinical field strength of 1.5 T, an endorectal coil
(ERC) is recommended for improving the signal-to-noise ratio
with subsequent spatial resolution to allow reliable cancer
delineation in a clinically reasonable time frame. Also, at 3
Tesla, the use of an ERC increases the signal-to-noise ratio
with improved image quality and allows better localization
and staging performance [11]. The ERC, however, must be
correctly positioned, and, if necessary, readjusted in order to
position the coil antenna in a plane perpendicular to the left-
right phase encoding direction. When incorrectly positioned
(e.g., it is inserted sidelong), the ERC can cause a character-
istic artefact on trace DWI or high b value calculated images.
This consists of a hyperintense area in the postero-lateral as-
pect of the peripheral zone, near to the wrongly placed antenna
(Fig. 24). However, the ADC maps and T2-weighted images
do not have this artefact. Thus if these images are Bnormal^,
the pathologic finding of the trace DWI or high b value images
can be excluded. The ERCmust also be correctly plugged into
a scanner interface. If not, signals captured by the ERC may
not be transmitted for image reconstruction, leaving a
hypointense curved artefact along the boundaries of the coil,
increased central image noise and low signal in the prostate
gland (image to be added). Patient or bowel movements dur-
ing image acquisition may cause repetitive circular artefacts
along the boundaries of the ERC (image to be added). They
can be minimized by rectal emptying and a spasmolytic drug
administered prior to the examination.
Post-biopsy Changes
Residual post-biopsy haemorrhage can lead to both false-
negative and false-positive results [16].Moreover, the damage
induced by the biopsy needle may determine a transient irreg-
ularity of the periprostatic capsule, leading to an overestima-
tion of extraprostatic tumour extension. The signal intensity
(SI) of post-biopsy haemorrhage on T1 and T2-weighted im-
ages changes depending on the state of haemoglobin degrada-
tion. Mp-MRI of the prostate should ideally be indicated at
least 2 months after biopsy when complete resorption of the
haemorrhage is expected. The post-biopsy haemorrhage ap-
pears as a hypointense zone on T2-weighted images and
shows a high SI on T1-weighted images. Because PCa ap-
pears as a low SI zone on T2-weighted with high SI on post-
contrast T1-weighted images, post-biopsy haemorrhage may
enclose a PCa focus and cause an overestimation of PCa ex-
tension. DW imaging may not be a very useful tool in identi-
fying the real pathological focus, because post-biopsy haem-
orrhage may show restricted diffusion phenomena of water
molecules with a low SI appearance on ADC maps. In this
context, post-contrast subtraction imaging is mandatory to de-
pict the suspicious focus of PCa because on T1-weighted sub-
traction images, the hyperintensity of the hematoma is effaced
and the enhancing nodule is well depicted (Fig. 25).
Lymphoceles
According to EAU guidelines, pelvic lymphadenectomy is
necessary if serum PSA level is>20 mg/dL or cT>2b or
Fig. 24 Mispositioned endorectal coil. a ADC map (DWI acquired with
b value = 1000 mm2/sec and b 3000 mm2/sec) showing focal low signal
intensity on the left side of the apex. b Gradient-echo T1-weighted
subtracted image showing at the same site strong focal enhancement.
According to the PIRADS v2 scoring system, the score for DWI and
DCE is, respectively, 4 and +, which means highly clinically significant
cancer is likely to be present. c Axial T2-weighted fast spin-echo image
(6006/110) display no differences in signal intensity between left and
right postero-lateral aspect, and it represents the decisive sequence
confirming the mispositioned endorectal coil
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Gleason>7. Lymphoceles may occur at the site of lymph
adenectomy and are found along the lymph node chains with-
in the pelvis and paraaortic region. Lymphoceles are fluid
filled cysts without an epithelial lining and have been reported
to occur in 12–24 % of patients [65]. They usually become
detectable 3–8 weeks after surgery, but may persist for up to a
year. They have low signal intensity on T1-weighted images
and intermediate to high signal intensity on T2-weighted im-
ages, and are typically thin-walled and unilocular and do not
enhance on MR images after intravenous contrast agent ad-
ministration (Fig. 26). They should not be confused with other
postoperative complications such as urinoma (direct anatomic
Fig. 26 MR images of a 64-year-old man with prostate-specific antigen
progression (PSA serum level 0.62 ng/mL) after radical retropubic
prostatectomy, with suspected local recurrence. a Axial T2-weighted
fast spin-echo (6200/112), b axial T2-weighted fat saturated fast spin-
echo (8300/112) and c coronal T2-weighted fast spin-echo (4110/114)
image showing a unilocular, thin walled hyperintense cystic-like mass
at the obturator lymph nodes location. d Axial post-contrast T1-
weighted fat saturated 3D FLASH (VIBE) image showing no signs of
enhancement of the cystic mass. e Axial ADC map reconstructed from
images obtained at b values of 0, 500 and 1000 s/mm2 show a bright area
corresponding to the cystic mass seen on T2-weighted images. These
findings are consistent with lymphocele (white arrows)
Fig. 25 Post-biopsy haemorrhage in the midgland of a 69-year-old man
with a PSA serum level of 4.7 ng/mL. aAxial T2-weighted fast spin-echo
image (5525/109) and b axial fat saturated T2-weighted fast spin-echo
image (5981/116) showing a large hypointense zone involving the left
posterior site of the midgland and a smaller zone of low signal intensity in
the contralateral side (white arrows). c The first axial perfusion gradient-
echo T1-weighted image acquired before the injection of contrast
medium displays diffuse high signal intensity in the midgland
representing recent post-biopsy haemorrhage. d Gradient-echo T1-
weighted subtracted image and e colour DCE MR map showing a real
hypervascular zone in the left midgland, which appear smaller in size than
in a, b and c. f Axial DWI image with b value = 1000 mm2/sec and g
3000 mm2/sec, and h ADC map showing mild diffusion restricted
phenomena in the left posterior aspect of the midperipheral zone.
Pathologic correlation after prostatectomy yielded prostate
adenocarcinoma, with a Gleason score of 6 in left midland
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contiguity with the urinary tract), hematoma (contains blood-
degradation products), abscess (thick walls, internal
septations, heterogenous content, marked wall enhancement,
surrounding inflammatory changes) or necrotic lymphade-
nopathy [18].
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